Asthma Treatment Best Hospitals China 2026

Why Asthma Patients Are Looking at China in 2026

Asthma affects roughly 260 million people worldwide, and while most cases are controlled with inhaled corticosteroids and bronchodilators, an estimated 5–10% of patients have severe asthma that does not respond to standard inhaler therapy. For those patients, the treatment conversation shifts quickly to biologics, specialized eosinophil testing, and sometimes bronchial thermoplasty — interventions that can cost tens of thousands of dollars per year in the United States. This is exactly the point where asthma treatment at the best hospitals in China 2026 becomes a serious, evidence-based option rather than a fringe idea.

China's respiratory medicine infrastructure has matured rapidly. The country carries one of the world's largest asthma burdens, which means its leading hospitals see enormous patient volumes every week. That volume translates into highly standardized diagnostic protocols, extensive experience with biologic selection, and pricing that reflects domestic pharmaceutical production rather than imported list prices. A patient in Texas paying USD 36,000 a year for mepolizumab and a patient in Shanghai paying a fraction of that are receiving the same molecule from the same class of manufacturers.

What makes 2026 different from even three years ago is the breadth of choice. China now has domestically developed biologics in late-stage development, expanded pediatric asthma programs, and international departments at major hospitals that are structured specifically to handle overseas patients. If you are weighing whether to travel, the honest answer is that China is an excellent fit for some patients and a poor fit for others — and this guide is written to help you tell the difference.

If you want to understand how we verify hospital quality before recommending any center, our hospital vetting methodology explains the accreditation, outcome and language-support criteria we apply.

What "Best" Actually Means for Asthma Care

Asthma is not a surgical specialty, so the usual "best hospital" rankings based on transplant volumes or cardiac outcomes do not translate directly. For asthma, quality shows up in five measurable places: the accuracy of the diagnostic workup, the sophistication of phenotype classification, access to the full range of biologics, the presence of a dedicated severe asthma clinic, and the quality of long-term follow-up planning.

The diagnostic workup is where good centers separate from average ones. A proper evaluation includes spirometry with bronchodilator reversibility, methacholine or mannitol challenge testing when the diagnosis is uncertain, fractional exhaled nitric oxide (FeNO), blood eosinophil counts, total and specific IgE panels, and often high-resolution CT to rule out alternative diagnoses. Centers that skip steps tend to over-diagnose or under-treat, and both errors are costly over a lifetime.

Phenotype classification matters because asthma is not one disease. Type 2 high asthma, driven by eosinophils and IgE, responds to biologics. Neutrophilic or paucigranulocytic asthma often does not. A hospital that runs the full panel can tell you within two weeks whether you are a biologic candidate — and if you are not, it can save you tens of thousands of dollars in futile therapy. This is the kind of detail that separates a genuine respiratory center of excellence from a general internal medicine department.

Finally, look for a severe asthma clinic that runs multidisciplinary reviews. At centers such as China-Japan Friendship Hospital in Beijing and Shanghai Ruijin Hospital, difficult cases are discussed jointly by pulmonologists, allergists, radiologists and sometimes ENT specialists, because chronic rhinosinusitis and nasal polyps frequently drive uncontrolled asthma. That integrated review is a hallmark of top-tier care.

The Leading Asthma Hospitals in China for 2026

China-Japan Friendship Hospital in Beijing is widely regarded as the country's flagship respiratory center. Its Department of Pulmonary and Critical Care Medicine, affiliated with the China-Japan Friendship Hospital and the Chinese Academy of Medical Sciences, handles a very high volume of severe and refractory asthma cases and runs an active clinical trials program. For international patients, the hospital's international medical department provides English-language coordination.

Shanghai Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, combines a strong respiratory department with an outstanding allergy and immunology service, which is valuable if your asthma overlaps with allergic rhinitis, eczema or food allergy. Zhongshan Hospital Fudan University, also in Shanghai, is another consistently top-ranked respiratory center with deep expertise in airway inflammation research.

In Guangzhou, The First Affiliated Hospital of Guangzhou Medical University is home to the State Key Laboratory of Respiratory Disease, one of the most cited respiratory research institutions in Asia. Its severe asthma program is among the most experienced in China with biologic therapy and bronchial thermoplasty. For patients in southern China or Southeast Asia, this is often the most practical high-quality option.

West China Hospital of Sichuan University in Chengdu serves western China and offers a full respiratory service with international patient support. Tongji Hospital in Wuhan and Peking Union Medical College Hospital in Beijing round out the list of centers we most often recommend. Peking Union in particular is the reference center for complex, undiagnosed or multi-system cases. You can browse additional verified centers on our partner hospital directory.

Asthma Treatment Costs in China vs the US, UK and Australia

The cost gap is the single biggest reason international patients consider China, and it is real. The table below reflects 2026 estimates for self-paying international patients at top-tier Chinese public hospitals, compared with typical private or self-pay pricing in the US, UK and Australia. Chinese public hospital pricing is regulated, which is why consultation and testing fees are remarkably low by Western standards.

Three caveats are worth stating plainly. First, these figures are for self-paying international patients; Chinese citizens with national insurance pay even less. Second, biologic pricing depends heavily on which agent you need and whether a domestic biosimilar is available — omalizumab, for instance, is now produced domestically in China and is considerably cheaper than imported alternatives. Third, you should budget separately for travel, accommodation and interpretation, which typically add USD 1,500–4,000 for a one-week trip depending on your origin city.

For a broader view of how hospital tiers and service levels map onto price, see our transparent pricing guide.

Biologic Therapy and Advanced Options Available in China

For severe eosinophilic or allergic asthma, biologics have transformed outcomes. Omalizumab targets IgE and is the oldest agent in the class. Mepolizumab, benralizumab and reslizumab target IL-5 pathways and are particularly effective in eosinophil-driven disease. Dupilumab blocks IL-4 receptor alpha and often helps patients who also have nasal polyps, atopic dermatitis or eosinophilic esophagitis. Tezepelumab, an anti-TSLP antibody, works upstream and has shown benefit even in patients with lower eosinophil counts.

All of these are approved and commercially available in China as of 2026, and major respiratory centers have established selection algorithms based on blood eosinophil count, FeNO, total IgE, sensitization profile and prior exacerbation frequency. If you have been told in your home country that you are "not quite eligible" for a biologic, a careful re-evaluation in China may change that picture — or confirm it, which is equally useful.

China is also a global site for clinical trials of novel asthma biologics, including domestically developed IL-4R alpha antibodies. Participation in a trial is not the same as routine care and requires careful informed consent, but for a small number of patients with truly refractory disease it can be worth discussing. Your treating pulmonologist, not a broker, should make that call.

Bronchial thermoplasty is available at a limited number of high-volume centers for patients with severe, poorly controlled asthma despite optimal medical therapy. It is not a first-line option, and the international evidence base suggests modest average benefit with meaningful variability between patients. A good Chinese center will tell you honestly whether you are a candidate.

How to Plan an Asthma Treatment Trip to China

Start with a records review, not a flight booking. Send your existing spirometry results, FeNO values, eosinophil counts, allergy testing, medication history and a summary of exacerbations over the past 12 months. A Chinese pulmonologist can usually tell from that packet whether you are a candidate for something they offer that you cannot access at home. If the answer is no, you have saved yourself a trip.

Once a hospital accepts your case, you will typically receive a written invitation letter for visa purposes and a proposed diagnostic schedule. Most international patients arrive on an M or S2 visa; the invitation letter is the key supporting document. Plan for 5–7 days on the ground for diagnosis and treatment planning, or 2–3 weeks if you are also doing pulmonary rehabilitation or starting and stabilizing a new therapy.

Practical details matter. Bring hard copies and digital copies of everything. Book accommodation within walking distance of the hospital if possible, because repeated visits for testing are common. Arrange interpretation in advance — even at hospitals with English-speaking doctors, the nursing, pharmacy and billing interactions often happen in Chinese. Our step-by-step patient journey guide walks through each stage from first inquiry to follow-up at home.

Finally, plan your transition home before you leave China. Ask for a written treatment plan in English, including drug names, doses, monitoring intervals and clear criteria for when to escalate. Take a supply of any new medication with you if permitted, and identify a local pulmonologist who can continue monitoring. Continuity is what turns a successful trip into a successful outcome.

Risks, Limitations and Who Should Not Travel

Asthma care in China is genuinely strong, but it is not the right answer for everyone. If your asthma is well controlled on a low-dose inhaler, there is no clinical reason to travel — the cost of a trip will exceed any savings. If you have a life-threatening exacerbation history with frequent ICU admissions, long-distance travel carries real risk and should only be undertaken with a written plan from your current physician.

Language and continuity are the two most common practical problems. Even with interpretation, nuance can be lost, and follow-up across time zones is harder than follow-up across town. Patients who do best are those who arrive with complete records, a clear question they want answered, and a realistic plan for continuing care at home.

Be skeptical of anyone promising a cure. Asthma is a chronic condition managed, not eliminated. Any provider — in China or anywhere else — who suggests otherwise is not practicing evidence-based medicine. The World Health Organization maintains useful background on asthma epidemiology and management principles at who.int, and peer-reviewed evidence on biologic efficacy is freely searchable through PubMed.

Frequently Asked Questions

How much does asthma treatment cost in China in 2026?

An initial specialist consultation at a top-tier Chinese public hospital typically costs USD 40–120. A full allergy and lung function workup runs USD 350–900, and one year of inhaled corticosteroid plus long-acting bronchodilator therapy costs roughly USD 250–700. Biologic therapy for severe asthma costs about USD 2,400–6,000 per year in China, versus USD 30,000–40,000 in the United States.

Which hospitals in China are best for severe asthma?

Leading centers include Peking Union Medical College Hospital and China-Japan Friendship Hospital in Beijing, Shanghai Ruijin Hospital and Zhongshan Hospital Fudan University in Shanghai, The First Affiliated Hospital of Guangzhou Medical University, West China Hospital of Sichuan University in Chengdu, and Tongji Hospital in Wuhan. All operate dedicated respiratory medicine departments with biologic and bronchoscopy services.

Is biologic therapy for asthma available in China?

Yes. Omalizumab, mepolizumab, benralizumab, dupilumab and tezepelumab are all approved and available at major Chinese respiratory centers. China also has domestically developed biologics in late-stage trials, which may lower costs further. Eligibility is determined by blood eosinophil counts, FeNO, IgE levels and exacerbation history.

Do doctors in China speak English?

At the international departments of top-tier hospitals, most senior pulmonologists speak working English and can review English-language medical records. Outside those departments, English support is limited. OrientHealthLink provides medical interpreters and translated reports for the entire visit.

How long do I need to stay in China for asthma treatment?

A diagnostic and treatment-planning visit usually takes 5–7 days, including lung function testing, allergy panels, imaging and a specialist review. Patients starting biologic therapy typically need 2–3 days for the first infusion or injection, then can continue maintenance doses locally under supervision. A longer 2–3 week stay is recommended if you also want pulmonary rehabilitation.

Can children receive asthma treatment in China?

Yes. Beijing Children's Hospital, Shanghai Children's Medical Center and the pediatric respiratory units at West China Second University Hospital are among the strongest pediatric asthma centers in Asia. They offer pediatric spirometry, exhaled nitric oxide testing, allergen immunotherapy and structured asthma action plans for families.

Related Reading

• Recovery and Rehabilitation in China: What Aftercare Really Looks Like
• Transferring Medical Records from China to the US: A Practical Guide
• West China Hospital Chengdu: Inside the International Department